Relationship among Insulin Resistance, Growth Hormone, and Insulin-Like Growth Factor I Concentrations in Diestrous Swedish Elkhounds

被引:13
作者
Strage, E. M. [1 ]
Lewitt, M. S. [2 ]
Hanson, J. M. [1 ]
Olsson, U. [3 ]
Norrvik, F. [4 ]
Lilliehook, I. [5 ]
Holst, B. S. [1 ]
Fall, T. [6 ]
机构
[1] Swedish Univ Agr Sci, Dept Clin Sci, S-75007 Uppsala, Sweden
[2] Univ West Scotland, Sch Hlth Nursing & Midwifery, Paisley, Renfrew, Scotland
[3] Swedish Univ Agr Sci, Dept Econ, S-75007 Uppsala, Sweden
[4] Albano Anim Hosp, Stockholm, Sweden
[5] Swedish Univ Agr Sci, Univ Anim Hosp, S-75007 Uppsala, Sweden
[6] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden
来源
JOURNAL OF VETERINARY INTERNAL MEDICINE | 2014年 / 28卷 / 02期
关键词
GH; Diestrus; Progesterone; IGF-I; CANINE MAMMARY-TUMORS; MEDROXYPROGESTERONE ACETATE; GLUCOSE-HOMEOSTASIS; PROGNOSTIC-FACTORS; DIABETES-MELLITUS; CANCER-RISK; DOGS; PROGESTERONE; SECRETION; OBESITY;
D O I
10.1111/jvim.12307
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background In the dog, the normal estrous cycle includes a prolonged luteal phase. Progesterone stimulates local canine mammary growth hormone (GH) production, which may act systemically and contribute to insulin resistance. Swedish Elkhounds are predisposed to progesterone-related diabetes mellitus, and the relationship among insulin resistance, GH, and insulin-like growth factor I (IGF-I) is of particular interest. Objective To study insulin resistance in relation to GH and IGF-I in nondiabetic Swedish Elkhounds during diestrus. We also assessed whether alterations in these hormones could predict diestrus-linked diseases and all-cause mortality. Animals Eighty-four privately owned female intact Swedish Elkhounds >4years of age. Methods Blood sampling and clinical examination during luteal phase, with a follow-up questionnaire after 20months. Insulin resistance was calculated by homeostasis model assessment (HOMA-IR). Results In multivariable regression analysis, GH was positively associated with HOMA-IR (P=.009). An increase in GH of 1ng/mL was associated with a 12.7% increase in HOMA-IR. Moreover, C-peptide was positively associated with IGF-I (P=.04), and an increase in C-peptide of 0.1ng/mL was associated with a 6.9% increase in IGF-I. Structural equation modeling supported these results. Twenty-three animals were found to have previously unrecognized mammary masses and had higher GH (P<.0001) and IGF-I (P=.007) than dogs without mammary masses (n=61). There was no association between high GH and IGF-I concentrations at sampling and future mammary masses. Conclusion We showed that GH was strongly associated with insulin resistance in older Swedish Elkhounds during diestrus.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 50 条
  • [41] Mecasermin (recombinant human insulin-like growth factor I)
    Arlan L. Rosenbloom
    Advances in Therapy, 2009, 26
  • [42] Bioactive Insulin-Like Growth Factor-I in Obesity
    Frystyk, J.
    Brick, D. J.
    Gerweck, A. V.
    Utz, A. L.
    Miller, K. K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08) : 3093 - 3097
  • [43] Growth hormone and insulin-like growth factor-I axis in type 1 diabetes
    Nambam, Bimota
    Schatz, Desmond
    GROWTH HORMONE & IGF RESEARCH, 2018, 38 : 49 - 52
  • [44] Relationship of Serum Total Insulin-Like Growth Factor Binding Protein-3 with Insulin-Like Growth Factor-I and Glucose Tolerance in Korean Children and Adolescents
    Kim, Sun-Young
    Kim, Minsun
    Oh, Youngman
    Lee, Dae-Yeol
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
  • [45] Serum concentrations of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and cardiovascular risk factors in adolescents
    Kong, Alice P. S.
    Choi, Kai-Chow
    Wong, Gary W. K.
    Ko, Gary T. C.
    Ho, Chung-Shun
    Chan, Michael H. M.
    Ozaki, Risa
    Ma, Ronald C. W.
    Lau, Joseph T. F.
    Chan, Juliana C. N.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 263 - 269
  • [46] Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients
    Invitti, C
    Fatti, L
    Camboni, MG
    Porcu, L
    Danesi, L
    Delitala, G
    Cavagnini, F
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1996, 19 (08) : 548 - 555
  • [47] Growth hormone and insulin-like growth factor I have different effects on bovine myoblasts and myotubes in culture
    Ge, X.
    Jiang, H.
    JOURNAL OF DAIRY SCIENCE, 2010, 93 : 200 - 200
  • [48] Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children
    G. Scirè
    C. Del Bianco
    G. L. Spadoni
    S. Cianfarani
    Journal of Endocrinological Investigation, 2008, 31 : 153 - 158
  • [49] Drug delivery of Insulin-like growth factor I
    Schultz, Isabel
    Wurzel, Joel
    Meinel, Lorenz
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 : 329 - 337
  • [50] The Relationship of Insulin-Like Growth Factor 2 to Fetal Growth and Adiposity
    Kadakia, Rachel
    Josefson, Jami
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 85 (02): : 75 - 82